Research powered investment banking
Home
Research
Companies
Find Alpha
Themes
Top Picks
Premium
Transactions
Events
Redeye
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Members network
Community
sign in
Home
research
Companies
Find Alpha
Themes
Top Picks
Transactions
Events
redeye
About
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Community
The latest from Redeye about Scandinavian Life Science and Technology companies

Vicore Pharma Holding

A First POC in Covid-19

Research Update 2021-01-25
VICO

Nanologica

Confirmation of Progress

Research Note 2021-01-25
NICA
Premium

Life Science Outlook 2021

Replay from Jan 19th

Premium Article 2021-01-22

Orexo

Zubsolv solidly maintains market share

Research Update 2021-01-20
ORX

Sensys Gatso Group

Impressive recruitment

Research Note 2021-01-20
SENS

PowerCell Sweden

BlackRock almost at 10%

Research Note 2021-01-20
PCELL
Premium

Strax

Goda framtidsutsikter för STRAX

Premium Article 2021-01-20
STRAX

Redeye Life Science Outlook 2021

Analysts’ Top Picks

Research Note 2021-01-21
ORPHA

Better Collective

Betting and Regulatory Tailwind

Research Note 2021-01-18
BETCO

Orexo

Change of policy positive for Zubsolv

Research Note 2021-01-20
ORX
Research
  • Research Note 2021-01-25

    Nanologica: Confirmation of Progress

    Mats Hyttinge
  • Research Update 2021-01-25

    Vicore Pharma: A First POC in Covid-19

    Ludvig Svensson
  • Research Note 2021-01-21

    Redeye Life Science Outlook 2021: Analysts’ Top Picks

    Oscar Bergman
  • Research Update 2021-01-20

    Orexo: Zubsolv solidly maintains market share

    Gergana Almquist
  • Research Note 2021-01-20

    Powercell: BlackRock almost at 10%

    Henrik Alveskog
  • Research Note 2021-01-20

    Sensys Gatso: Impressive recruitment

    Viktor Westman
Read all
Community
  • 2021-01-25

    Lumito - Påsen knyts ihop!

    Mr FlySky
  • 2021-01-25

    TF Bank – Snabb 50-procentig uppsida

    Långtradaren
  • 2021-01-24

    E-handlarna slår världsrekord - Lyko står ut i mängden

    Ecomm-Analyst
  • 2021-01-22

    Adverty – indirekt storvinnare på gamingboomen

    carpe_diem
  • 2021-01-19

    Prostalund - Nu en game-changer på en mångmiljard marknad

    appelbrand
  • 2021-01-18

    PolarCool - Global expansion - BrainCool satsar med FDA/USA

    markin
Read all
  • Office
  • Mäster Samuelsgatan 42, 10th floor
  • Box 7141, 103 87
  • Stockholm, Sweden
  • info@redeye.se
  • +46 (0)8 545 013 30
  • Services
  • Home
  • Research
  • Transactions
  • Events
  • Redeye
  • Community
  • Members Home
  • Premium
  • Legal
  • Terms and conditions (Swedish)
  • Terms of membership (Swedish)
  • Terms and conditions - Advisory (Swedish)
  • Terms and conditions - Advisory (English)
  • Integrity Policy (Swedish)
  • Disclaimer (Swedish)
  • Governance
  • Follow
  • Twitter
  • Facebook
  • LinkedIn
  • Redeye
  • At a Glance
  • Our Culture
  • Investor Services
  • Corporate Broking
  • Corporate Finance
  • Newsroom
  • The Team
  • Careers
  • FAQ

© All rights reserved. Redeye AB is authorised and regulated by the Swedish Financial Supervisory Authority, Finansinspektionen. 2021